| VRTX | Vertex Pharmaceuticals Inc | $111.13B | +7129110.05% |
| VRNA | Verona Pharma Plc | $77.75B | +4987749.83% |
| REGN | Regeneron Pharmaceuticals Inc | $65.28B | +4188226.95% |
| ARGX | Argen X SE | $54.32B | +3484983.05% |
| ALNY | Alnylam Pharmaceuticals Inc | $39.13B | +2510544.32% |
| RVMD | Revolution Medicines Inc | $30.63B | +1964782.43% |
| RPRX | Royalty Pharma plc - Class A | $23.57B | +1512250.80% |
| BNTX | BioNTech SE | $23.52B | +1508701.76% |
| INSM | Insmed Inc | $23.04B | +1477887.54% |
| ROIV | Roivant Sciences Ltd | $21.31B | +1366906.57% |
| INCY | Incyte Corp | $19.46B | +1248538.47% |
| MRNA | Moderna Inc | $18.90B | +1212495.98% |
| GMAB | Genmab | $17.06B | +1094106.01% |
| ASND | Ascendis Pharma A/S | $15.18B | +973729.64% |
| JAZZ | Jazz Pharmaceuticals plc | $14.70B | +943290.29% |
| SMMT | Summit Therapeutics Inc | $13.47B | +864168.44% |
| BBIO | BridgeBio Pharma Inc | $13.00B | +834089.99% |
| EXEL | Exelixis Inc | $12.69B | +814191.90% |
| IONS | Ionis Pharmaceuticals Inc | $12.69B | +814011.49% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.16B | +779924.90% |
| AXSM | Axsome Therapeutics Inc | $12.06B | +773547.54% |
| ARWR | Arrowhead Pharmaceuticals Inc | $11.10B | +712253.04% |
| ABVX | Abivax | $10.29B | +659822.26% |
| BMRN | Biomarin Pharmaceutical Inc | $10.12B | +649363.63% |
| PRAX | Praxis Precision Medicines Inc | $9.95B | +638203.61% |
| CYTK | Cytokinetics Inc | $9.51B | +610042.57% |
| KRYS | Krystal Biotech Inc | $9.03B | +578976.08% |
| NUVL | Nuvalent Inc - Class A | $8.45B | +541853.51% |
| IBRX | ImmunityBio Inc | $8.26B | +530042.48% |
| HALO | Halozyme Therapeutics Inc | $8.14B | +521900.13% |
| TECH | Bio-Techne Corp | $7.53B | +482782.21% |
| MTSR | Metsera Inc | $7.40B | +474941.62% |
| PCVX | Vaxcyte Inc | $7.36B | +472266.73% |
| CORT | Corcept Therapeutics Inc | $6.96B | +446453.67% |
| MRUS | Merus N.V | $6.83B | +437798.71% |
| IMVT | Immunovant Inc | $6.81B | +437026.44% |
| KYMR | Kymera Therapeutics Inc | $6.71B | +430651.43% |
| ACLX | Arcellx Inc | $6.67B | +427549.55% |
| PTGX | Protagonist Therapeutics Inc | $6.56B | +421051.98% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +416536.95% |
| CELC | Celcuity Inc | $6.48B | +415435.40% |
| RYTM | Rhythm Pharmaceuticals Inc | $6.26B | +401331.00% |
| CNTA | Centessa Pharmaceuticals plc | $6.15B | +394679.55% |
| SRRK | Scholar Rock Holding Corp | $6.03B | +386842.70% |
| TGTX | TG Therapeutics Inc | $6.00B | +384909.40% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +381465.06% |
| MIRM | Mirum Pharmaceuticals Inc | $5.93B | +380332.84% |
| COGT | Cogent Biosciences Inc | $5.89B | +377988.65% |
| PTCT | PTC Therapeutics Inc | $5.86B | +375617.49% |
| APGE | Apogee Therapeutics Inc | $5.82B | +373414.58% |
| SYRE | Spyre Therapeutics Inc | $5.72B | +366650.89% |
| BLTE | Belite Bio Inc | $5.59B | +358512.04% |
| CGON | Cg Oncology Inc | $5.35B | +343182.75% |
| LEGN | Legend Biotech Corp | $5.26B | +337666.83% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +336626.73% |
| XENE | Xenon Pharmaceuticals Inc | $5.21B | +334019.46% |
| CRSP | CRISPR Therapeutics AG | $5.16B | +330906.41% |
| DNTH | Dianthus Therapeutics Inc | $4.73B | +303395.07% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.72B | +303007.18% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +288869.65% |
| TVTX | Travere Therapeutics Inc | $4.41B | +283027.02% |
| AKRO | Akero Therapeutics Inc | $4.38B | +280906.84% |
| CAI | Caris Life Sciences Inc - Class A | $4.35B | +278790.60% |
| NAMS | NewAmsterdam Pharma Company NV | $4.26B | +273481.86% |
| ERAS | Erasca Inc | $3.88B | +248547.74% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.87B | +248466.92% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +245401.39% |
| VKTX | Viking Therapeutics Inc | $3.67B | +235296.00% |
| ACAD | Acadia Pharmaceuticals Inc | $3.63B | +232480.55% |
| EWTX | Edgewise Therapeutics Inc | $3.60B | +231172.66% |
| TLX | Telix Pharmaceuticals Ltd | $3.30B | +211590.61% |
| BEAM | Beam Therapeutics Inc | $3.28B | +210098.36% |
| DNLI | Denali Therapeutics Inc | $3.21B | +205607.97% |
| RCUS | Arcus Biosciences Inc | $3.01B | +192891.95% |
| DYN | Dyne Therapeutics Inc | $3.00B | +192367.24% |
| ORKA | ARCA biopharma Inc | $2.91B | +186539.72% |
| TNGX | Tango Therapeutics Inc | $2.83B | +181636.61% |
| GPCR | Structure Therapeutics Inc | $2.81B | +180179.50% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +175784.76% |
| RLAY | Relay Therapeutics Inc | $2.73B | +175060.67% |
| ALMS | Alumis Inc | $2.67B | +171021.36% |
| IRON | Disc Medicine Inc | $2.66B | +170818.41% |
| ARQT | Arcutis Biotherapeutics Inc | $2.64B | +169565.57% |
| TARS | Tarsus Pharmaceuticals Inc | $2.58B | +165666.36% |
| IDYA | Ideaya Biosciences Inc | $2.57B | +164932.96% |
| ELVN | Enliven Therapeutics Inc | $2.52B | +161661.88% |
| IMNM | Immunome Inc | $2.50B | +160428.76% |
| MLYS | Mineralys Therapeutics Inc | $2.47B | +158648.69% |
| VERA | Vera Therapeutics Inc - Class A | $2.45B | +157046.75% |
| ETNB | 89bio Inc | $2.34B | +150210.39% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.30B | +147406.51% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +142144.58% |
| KOD | Kodiak Sciences Inc | $2.18B | +139823.82% |
| CLDX | Celldex Therapeutics Inc | $2.11B | +135067.72% |
| ZLAB | Zai Lab Ltd | $2.08B | +133022.27% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.03B | +130273.67% |
| MESO | Mesoblast Ltd | $2.02B | +129373.91% |
| TYRA | Tyra Biosciences Inc | $1.97B | +126451.87% |
| SION | Sionna Therapeutics Inc | $1.96B | +125491.22% |
| STOK | Stoke Therapeutics Inc | $1.96B | +125479.89% |
| NBTX | Nanobiotix | $1.94B | +124147.78% |
| AAPG | Ascentage Pharma Group International | $1.93B | +123886.65% |
| PHVS | Pharvaris NV | $1.92B | +123368.38% |
| IOVA | Iovance Biotherapeutics Inc | $1.91B | +122725.52% |
| GLPG | Galapagos NV | $1.90B | +121682.47% |
| RAPP | Rapport Therapeutics Inc | $1.89B | +121079.76% |
| OCUL | Ocular Therapeutix Inc | $1.87B | +119829.20% |
| TRVI | Trevi Therapeutics Inc | $1.86B | +118941.30% |
| ADMA | Adma Biologics Inc | $1.84B | +117926.96% |
| NVAX | Novavax Inc | $1.82B | +116882.37% |
| ZYME | Zymeworks BC Inc | $1.81B | +116161.87% |
| NRIX | Nurix Therapeutics Inc | $1.81B | +115788.43% |
| HRMY | Harmony Biosciences Holdings Inc | $1.78B | +114095.15% |
| VRDN | Viridian Therapeutics Inc | $1.77B | +113352.61% |
| SRPT | Sarepta Therapeutics Inc | $1.76B | +112871.45% |
| VCEL | Vericel Corp | $1.75B | +112049.38% |
| OCS | Oculis Holding AG | $1.74B | +111797.42% |
| SNDX | Syndax Pharmaceuticals Inc | $1.74B | +111294.46% |
| BHVN | Biohaven Ltd | $1.70B | +108912.58% |
| AGIO | Agios Pharmaceuticals Inc | $1.70B | +108856.81% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.68B | +107813.90% |
| CAPR | Capricor Therapeutics Inc | $1.68B | +107702.00% |
| ANAB | AnaptysBio Inc | $1.67B | +107345.13% |
| PVLA | Palvella Therapeutics Inc | $1.66B | +106659.96% |
| ABCL | AbCellera Biologics Inc | $1.65B | +105977.23% |
| TSHA | Taysha Gene Therapies Inc | $1.65B | +105873.18% |
| NUVB | Nuvation Bio Inc - Class A | $1.64B | +105269.18% |
| INVA | Innoviva Inc | $1.63B | +104688.18% |
| NTLA | Intellia Therapeutics Inc | $1.62B | +103754.32% |
| NKTR | Nektar Therapeutics | $1.62B | +103685.29% |
| GLUE | Monte Rosa Therapeutics Inc | $1.62B | +103602.43% |
| QURE | uniQure N.V. | $1.59B | +101684.19% |
| ATAI | ATAI Life Sciences N.V. | $1.58B | +101214.90% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +100263.34% |
| SLS | SELLAS Life Sciences Group Inc | $1.56B | +99713.79% |
| PGEN | Precigen Inc | $1.55B | +99468.46% |
| IMTX | Immatics N.V | $1.53B | +98287.79% |
| ARDX | Ardelyx Inc | $1.52B | +97660.36% |
| MBX | MBX Biosciences Inc | $1.52B | +97193.34% |
| INBX | Inhibrx Biosciences Inc | $1.50B | +96423.75% |
| VIR | Vir Biotechnology Inc | $1.47B | +94029.47% |
| IMCR | Immunocore Holdings plc | $1.45B | +92906.55% |
| URGN | UroGen Pharma Ltd | $1.43B | +91552.07% |
| BCAX | Bicara Therapeutics Inc | $1.41B | +90646.93% |
| GHRS | GH Research PLC | $1.39B | +88887.55% |
| KALV | KalVista Pharmaceuticals Inc | $1.37B | +87961.92% |
| SEPN | Septerna Inc | $1.34B | +85742.93% |
| MPLT | MapLight Therapeutics Inc | $1.34B | +85605.57% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.31B | +84080.25% |
| MAZE | Maze Therapeutics Inc | $1.30B | +83022.80% |
| FTRE | FORTE SOFTWARE INC | $1.27B | +81346.25% |
| AVBP | ArriVent BioPharma Inc | $1.24B | +79749.10% |
| TRML | Tourmaline Bio Inc | $1.24B | +79177.37% |
| WVE | Wave Life Sciences Ltd | $1.22B | +78131.35% |
| ZBIO | Zenas Biopharma Inc | $1.13B | +72299.39% |
| OLMA | Olema Pharmaceuticals Inc | $1.13B | +72232.24% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.10B | +70357.18% |
| MNKD | Mannkind Corp | $1.10B | +70253.22% |
| DBVT | DBV Technologies | $1.10B | +70172.13% |
| CRVS | Corvus Pharmaceuticals Inc | $1.09B | +69654.54% |
| SVRA | Savara Inc | $1.07B | +68394.24% |
| JBIO | Jade Biosciences Inc | $1.06B | +67964.01% |
| CVAC | CureVac N.V. | $1.05B | +67217.72% |
| ANNX | Annexon Inc | $1.05B | +67053.04% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +63972.26% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +63404.47% |
| CGEM | Cullinan Oncology Inc | $953.73M | +61085.82% |
| PHAR | Pharming Group N.V. | $940.58M | +60242.66% |
| LXRX | Lexicon Pharmaceuticals Inc | $923.79M | +59165.15% |
| ABUS | Arbutus Biopharma Corp | $913.84M | +58526.84% |
| KURA | Kura Oncology Inc | $908.93M | +58212.19% |
| DRTS | Alpha Tau Medical Ltd | $905.62M | +57999.65% |
| ORIC | ORIC Pharmaceuticals Inc | $887.91M | +56863.68% |
| JANX | Janux Therapeutics Inc | $878.90M | +56285.25% |
| XNCR | Xencor Inc | $868.03M | +55588.08% |
| PHAT | Phathom Pharmaceuticals Inc | $853.21M | +54637.37% |
| SPRY | ARS Pharmaceuticals Inc | $844.05M | +54049.72% |
| GERN | Geron Corp | $843.41M | +54008.75% |
| EVMN | Evommune Inc | $841.03M | +53855.83% |
| VOR | Vor Biopharma Inc | $840.96M | +53851.42% |
| TBPH | Theravance Biopharma Inc | $837.63M | +53638.02% |
| DRUG | Bright Minds Biosciences Inc | $834.70M | +53449.79% |
| SANA | Sana Biotechnology Inc | $825.64M | +52868.56% |
| MGTX | MeiraGTx Holdings plc | $805.50M | +51576.63% |
| LBRX | LB Pharmaceuticals Inc | $797.16M | +51041.45% |
| ABSI | Absci Corp | $789.28M | +50536.12% |
| CMRX | Chimerix Inc | $766.03M | +49044.31% |
| RLMD | Relmada Therapeutics Inc | $761.50M | +48753.88% |
| ANRO | Alto Neuroscience Inc | $714.55M | +45741.63% |
| ATXS | Astria Therapeutics Inc | $709.95M | +45446.58% |
| DSGN | Design Therapeutics Inc | $693.10M | +44365.51% |
| SLDB | Solid Biosciences Inc | $690.73M | +44213.53% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $683.16M | +43727.73% |
| CTMX | CytomX Therapeutics Inc | $675.41M | +43230.63% |
| CRMD | CorMedix Inc | $663.22M | +42448.85% |
| IVA | Inventiva | $655.21M | +41935.00% |
| ZVRA | Zevra Therapeutics Inc | $647.31M | +41427.73% |
| CABA | Cabaletta Bio Inc | $640.38M | +40983.57% |
| ACRS | Aclaris Therapeutics Inc | $639.61M | +40933.89% |
| PRME | Prime Medicine Inc | $596.03M | +38138.11% |
| CADL | Candel Therapeutics Inc | $589.73M | +37733.59% |
| CBIO | Crescent Biopharma Inc | $573.22M | +36674.70% |
| TECX | AvroBio Inc | $573.01M | +36661.21% |
| CLYM | Eliem Therapeutics Inc | $571.31M | +36552.25% |
| ARVN | Arvinas Inc | $570.83M | +36521.02% |
| ALLO | Allogene Therapeutics Inc | $550.84M | +35238.69% |
| VALN | Valneva SE | $545.52M | +34897.76% |
| RIGL | Rigel Pharmaceuticals | $542.79M | +34722.17% |
| GYRE | Gyre Therapeutics Inc | $540.72M | +34589.37% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $538.30M | +34434.31% |
| MDXG | Mimedx Group Inc | $537.64M | +34392.19% |
| PRTA | Prothena Corporation plc | $532.36M | +34053.61% |
| KYTX | Kyverna Therapeutics Inc | $519.97M | +33258.71% |
| CTNM | Contineum Therapeutics Inc - Class A | $501.84M | +32095.09% |
| XOMA | XOMA Corp | $497.12M | +31792.33% |
| STRO | Sutro Biopharma Inc | $491.87M | +31455.59% |
| OCGN | Ocugen Inc | $466.88M | +29852.48% |
| SVA | Sinovac Biotech Ltd | $464.94M | +29727.93% |
| IMMX | Immix Biopharma Inc | $462.80M | +29590.44% |
| FDMT | 4D Molecular Therapeutics Inc | $462.60M | +29578.15% |
| STTK | Shattuck Labs Inc | $458.03M | +29284.43% |
| FULC | Fulcrum Therapeutics Inc | $451.60M | +28872.38% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +28860.07% |
| UPB | Upstream Bio Inc | $449.51M | +28738.05% |
| AUTL | Autolus Therapeutics plc | $447.12M | +28584.84% |
| ADCT | Adc Therapeutics SA | $438.08M | +28005.07% |
| ASMB | Assembly Biosciences Inc | $435.45M | +27836.13% |
| MNPR | Monopar Therapeutics Inc | $432.42M | +27641.99% |
| AURA | Aura Biosciences Inc | $430.49M | +27517.84% |
| OVID | Ovid Therapeutics Inc | $424.86M | +27156.50% |
| NGNE | Neoleukin Therapeutics Inc | $419.60M | +26819.00% |
| IPSC | Century Therapeutics Inc | $415.14M | +26532.86% |
| ZURA | Zura Bio Ltd - Class A | $408.94M | +26135.09% |
| CMPX | Compass Therapeutics Inc | $408.80M | +26126.36% |
| CYBN | Cybin Inc | $408.43M | +26102.77% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +25803.25% |
| GLSI | Greenwich LifeSciences Inc | $403.22M | +25768.11% |
| BNTC | Benitec Biopharma Inc | $398.51M | +25466.25% |
| LYEL | Lyell Immunopharma Inc | $390.28M | +24938.49% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +24932.35% |
| CCCC | C4 Therapeutics Inc | $389.10M | +24862.27% |
| VNDA | Vanda Pharmaceuticals Inc | $388.47M | +24822.28% |
| ENTA | Enanta Pharmaceuticals Inc | $383.31M | +24491.37% |
| RVNC | Revance Therapeutics Inc | $380.38M | +24302.92% |
| XFOR | X4 Pharmaceuticals Inc | $380.11M | +24285.68% |
| LXEO | Lexeo Therapeutics Inc | $377.10M | +24092.77% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +24085.22% |
| OABI | OmniAb Inc | $374.99M | +23957.32% |
| REPL | Replimune Group Inc | $374.27M | +23910.90% |
| ALT | Altimmune Inc | $373.67M | +23872.94% |
| VSTM | Verastem Inc | $373.33M | +23850.99% |
| EPRX | Eupraxia Pharmaceuticals Inc | $372.92M | +23824.74% |
| PBYI | Puma Biotechnology Inc | $371.93M | +23760.81% |
| LRMR | Larimar Therapeutics Inc | $365.67M | +23359.26% |
| CLLS | Cellectis | $364.91M | +23310.89% |
| AVIR | Atea Pharmaceuticals Inc | $364.12M | +23260.16% |
| EDIT | Editas Medicine Inc | $349.39M | +22314.65% |
| PALI | Palisade Bio Inc | $346.56M | +22133.59% |
| RGNX | Regenxbio Inc | $345.32M | +22053.70% |
| IMRX | Immuneering Corp Class A | $344.95M | +22030.42% |
| FENC | Fennec Pharmaceuticals Inc | $344.37M | +21993.14% |
| PRLD | Prelude Therapeutics Inc | $343.28M | +21923.17% |
| FBRX | Forte Biosciences Inc | $340.15M | +21722.30% |
| IMAB | I-Mab | $339.64M | +21689.20% |
| NMRA | Neumora Therapeutics Inc | $334.56M | +21363.67% |
| DMAC | DiaMedica Therapeutics Inc | $328.69M | +20986.86% |
| LCTX | Lineage Cell Therapeutics Inc | $326.58M | +20851.64% |
| RCKT | Rocket Pharmaceuticals Inc | $326.28M | +20832.33% |
| NAUT | Nautilus Biotechnology Inc | $325.30M | +20769.50% |
| ABEO | Abeona Therapeutics Inc | $323.57M | +20658.47% |
| SLN | Silence Therapeutics Plc | $321.20M | +20506.14% |
| RZLT | Rezolute Inc | $319.69M | +20409.60% |
| IVVD | Invivyd Inc | $319.57M | +20401.76% |
| BCYC | Bicycle Therapeutics Plc | $318.56M | +20337.14% |
| ANL | Adlai Nortye Ltd | $317.46M | +20266.21% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +19470.99% |
| SCPH | scPharmaceuticals Inc | $304.59M | +19440.86% |
| NAGE | Niagen Bioscience Inc | $304.32M | +19423.53% |
| SRZN | Surrozen Inc | $304.03M | +19404.61% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +19329.97% |
| ELDN | Eledon Pharmaceuticals Inc | $295.82M | +18878.31% |
| IRD | Ocuphire Pharma Inc | $295.61M | +18864.48% |
| ARMP | Armata Pharmaceuticals Inc | $289.32M | +18461.18% |
| ACIU | AC Immune SA | $289.11M | +18447.90% |
| TENX | Tenax Therapeutics Inc | $288.39M | +18401.72% |
| ZNTL | Zentalis Pharmaceuticals Inc | $286.05M | +18251.25% |
| YDES | YD Bio Ltd | $278.91M | +17793.32% |
| MGNX | Macrogenics Inc | $278.39M | +17760.18% |
| FATE | Fate Therapeutics Inc | $275.57M | +17578.80% |
| CNTX | Context Therapeutics Inc | $273.80M | +17465.51% |
| SABS | SAB Biotherapeutics Inc | $272.68M | +17393.69% |
| NVCT | Nuvectis Pharma Inc | $269.23M | +17172.60% |
| ALXO | Alx Oncology Holdings Inc | $263.70M | +16817.54% |
| TARA | Protara Therapeutics Inc | $262.06M | +16712.63% |
| CGEN | Compugen Ltd | $260.97M | +16642.21% |
| TRDA | Entrada Therapeutics Inc | $257.38M | +16412.14% |
| CHRS | Coherus Biosciences Inc | $256.00M | +16323.64% |
| AVXL | Anavex Life Sciences Corporation | $255.77M | +16309.07% |
| HUMA | Humacyte Inc | $255.32M | +16280.07% |
| FHTX | Foghorn Therapeutics Inc | $250.69M | +15983.15% |
| ALEC | Alector Inc | $245.37M | +15641.32% |
| LENZ | LENZ Therapeutics Inc | $242.37M | +15449.10% |
| THRD | Third Harmonic Bio Inc | $241.86M | +15416.71% |
| CDXS | Codexis Inc | $239.96M | +15294.54% |
| VYGR | Voyager Therapeutics Inc | $237.02M | +15105.93% |
| ADAG | Adagene Inc | $236.93M | +15100.01% |
| NKTX | Nkarta Inc | $236.88M | +15097.12% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +14848.77% |
| OBIO | Orchestra BioMed Holdings Inc | $231.59M | +14757.64% |
| NERV | Minerva Neurosciences Inc | $230.61M | +14694.61% |
| SLRN | Acelyrin Inc | $228.54M | +14562.16% |
| WHWK | Whitehawk Therapeutics Inc | $225.60M | +14373.24% |
| IKT | Inhibikase Therapeutics Inc | $224.46M | +14299.84% |
| CRBU | Caribou Biosciences Inc | $223.96M | +14267.88% |
| KROS | Keros Therapeutics Inc | $223.18M | +14217.91% |
| RNA | Atrium Therapeutics Inc | $222.37M | +14166.26% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +13924.67% |
| ARCT | Arcturus Therapeutics Holdings Inc | $217.72M | +13867.74% |
| SLGL | Sol-Gel Technologies Ltd | $205.59M | +13089.60% |
| KPTI | Karyopharm Therapeutics Inc | $202.45M | +12887.77% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +12846.77% |
| ELTX | Elicio Therapeutics Inc | $200.75M | +12779.13% |
| KRRO | Korro Bio Inc | $198.45M | +12631.76% |
| RNAC | Cartesian Therapeutics Inc | $197.81M | +12590.73% |
| DTIL | Precision Biosciences Inc | $195.87M | +12465.74% |
| IMUX | Immunic Inc | $190.70M | +12134.32% |
| QTTB | Q32 Bio Inc | $187.99M | +11960.32% |
| ENLV | Enlivex Therapeutics Ltd | $185.63M | +11809.16% |
| MDWD | MediWound Ltd | $184.49M | +11735.57% |
| ABOS | Acumen Pharmaceuticals Inc | $183.46M | +11669.67% |
| THAR | Tharimmune Inc | $183.00M | +11640.27% |
| IFRX | InflaRx N.V. | $182.18M | +11587.55% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +11499.88% |
| UNCY | Unicycive Therapeutics Inc | $178.43M | +11347.17% |
| GALT | Galectin Therapeutics Inc | $177.81M | +11307.55% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +11033.56% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $172.60M | +10973.02% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $172.60M | +10972.79% |
| HRTX | Heron Therapeutics Inc | $172.54M | +10969.22% |
| TNYA | Tenaya Therapeutics Inc | $171.88M | +10927.19% |
| RANI | Rani Therapeutics Holdings Inc Class A | $171.00M | +10870.18% |
| SPRO | Spero Therapeutics Inc | $169.62M | +10782.03% |
| PLX | Protalix BioTherapeutics Inc | $169.28M | +10760.06% |
| THTX | Theratechnologies Inc | $167.34M | +10635.40% |
| ANTX | AN2 Therapeutics Inc | $166.61M | +10589.00% |
| EQ | Equillium Inc | $166.29M | +10567.99% |
| MIST | Milestone Pharmaceuticals Inc | $164.91M | +10479.87% |
| PRQR | ProQR Therapeutics N.V | $164.37M | +10444.77% |
| MENS | Jyong Biotech Ltd | $164.22M | +10435.49% |
| ORMP | Oramed Pharmaceuticals Inc | $162.89M | +10349.86% |
| IPHA | Innate Pharma | $159.97M | +10162.87% |
| TTRX | Turn Therapeutics Inc | $157.58M | +10009.39% |
| MOLN | Molecular Partners AG | $154.89M | +9836.61% |
| VXRT | Vaxart Inc | $153.61M | +9754.89% |
| HURA | TuHURA Biosciences Inc | $151.32M | +9607.67% |
| NBP | NovaBridge Biosciences. | $150.91M | +9581.69% |
| CNTB | Connect Biopharma Holdings Ltd | $150.51M | +9555.78% |
| AKTX | Akari Therapeutics Plc | $148.12M | +9402.86% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +9225.27% |
| INDP | Indaptus Therapeutics Inc | $143.82M | +9126.56% |
| NRXP | NRX Pharmaceuticals Inc | $143.26M | +9090.60% |
| PROK | ProKidney Corp - Class A | $137.85M | +8743.71% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +8729.34% |
| GNLX | Genelux Corp | $137.21M | +8702.75% |
| GUTS | Fractyl Health Inc | $136.31M | +8644.98% |
| BDTX | Black Diamond Therapeutics Inc | $132.37M | +8391.95% |
| AGEN | Agenus Inc | $131.36M | +8327.29% |
| ACOG | Alpha Cognition Inc | $124.77M | +7904.28% |
| CRDF | Cardiff Oncology Inc | $123.75M | +7839.11% |
| KLRS | Kalaris Therapeutics Inc | $120.48M | +7629.31% |
| NTHI | NeOnc Technologies Holdings Inc | $120.03M | +7600.46% |
| SEER | Seer Inc - Class A | $115.64M | +7318.97% |
| ENGN | enGene Holdings Inc | $115.22M | +7292.01% |
| RPTX | Repare Therapeutics Inc | $113.91M | +7207.99% |
| COYA | Coya Therapeutics Inc | $111.89M | +7078.30% |
| PYXS | Pyxis Oncology Inc | $108.70M | +6873.47% |
| VANI | Vivani Medical Inc | $108.35M | +6851.11% |
| CGTX | Cognition Therapeutics Inc | $106.33M | +6721.62% |
| HLVX | HilleVax Inc | $104.74M | +6619.48% |
| ONCY | Oncolytics Biotech Inc | $104.52M | +6605.13% |
| VRCA | Verrica Pharmaceuticals Inc | $104.10M | +6578.71% |
| ALDX | Aldeyra Therapeutics Inc | $103.15M | +6517.48% |
| PEPG | PepGen Inc | $103.13M | +6516.14% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +6469.64% |
| BMEA | Biomea Fusion Inc | $98.33M | +6208.14% |
| CBUS | Cibus Global Ltd. Class A | $97.80M | +6174.53% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +6170.49% |
| ICCC | Immucell Corp | $96.17M | +6069.58% |
| PMN | ProMIS Neurosciences Inc | $93.94M | +5926.46% |
| ATHA | Athira Pharma Inc | $92.15M | +5811.87% |
| FBIO | Fortress Biotech Inc | $91.60M | +5776.25% |
| PTHS | Channel Therapeutics Corporation | $90.85M | +5728.62% |
| ATRA | Atara Biotherapeutics Inc | $89.72M | +5655.72% |
| ANIX | Anixa Biosciences Inc | $88.68M | +5589.10% |
| EXOZ | Invizyne Technologies Inc | $88.10M | +5551.81% |
| INO | Inovio Pharmaceuticals Inc | $87.22M | +5495.34% |
| AARD | Aardvark Therapeutics Inc | $87.05M | +5484.48% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +5480.82% |
| PYPD | Polypid Ltd | $86.83M | +5470.74% |
| NRXS | Neuraxis Inc | $85.30M | +5372.56% |
| LPTX | Leap Therapeutics Inc | $84.76M | +5337.66% |
| CSBR | Champions Oncology Inc | $82.35M | +5183.05% |
| ACET | Adicet Bio Inc | $81.58M | +5133.75% |
| HYFT | MindWalk Holdings Corp | $79.54M | +5002.97% |
| MAIA | MAIA Biotechnology Inc | $79.48M | +4998.98% |
| SGMO | Sangamo Therapeutics Inc | $77.92M | +4899.13% |
| FBIOP | Fortress Biotech Inc | $77.72M | +4886.10% |
| RLYB | Rallybio Corp | $76.87M | +4831.38% |
| PLRX | Pliant Therapeutics Inc | $76.77M | +4825.41% |
| GANX | Gain Therapeutics Inc | $75.20M | +4724.73% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | +4691.29% |
| XBIT | XBiotech Inc | $74.39M | +4672.46% |
| OSTX | OS Therapies Inc | $74.24M | +4662.56% |
| MCRB | Seres Therapeutics Inc | $73.19M | +4595.44% |
| SAVA | Cassava Sciences Inc. | $72.46M | +4548.76% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +4514.38% |
| EDSA | Edesa Biotech Inc | $70.82M | +4443.37% |
| BYSI | BeyondSpring Inc | $70.31M | +4411.02% |
| ATHE | Alterity Therapeutics Ltd | $68.71M | +4308.24% |
| SPRB | Spruce Biosciences Inc | $67.96M | +4259.64% |
| CUE | Cue Biopharma Inc | $66.52M | +4167.77% |
| IMA | Ikena Oncology Inc | $66.48M | +4165.18% |
| MNOV | Medicinova Inc | $65.46M | +4099.83% |
| IBIO | iBio Inc | $64.94M | +4066.32% |
| ACRV | Acrivon Therapeutics Inc | $64.32M | +4026.21% |
| PMVP | PMV Pharmaceuticals Inc | $64.00M | +4005.77% |
| IMMP | Immutep Ltd | $63.92M | +4000.85% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +3977.23% |
| OKYO | OKYO Pharma Ltd - New | $63.24M | +3957.26% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +3955.85% |
| PDSB | PDS Biotechnology Corporation | $61.96M | +3874.72% |
| OTLK | Outlook Therapeutics Inc | $61.25M | +3829.57% |
| GLTO | Galecto Inc | $60.81M | +3801.22% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +3697.93% |
| ANVS | Annovis Bio Inc | $57.22M | +3570.75% |
| DWTX | Virios Therapeutics Inc | $57.12M | +3564.29% |
| ENTX | Entera Bio Ltd | $55.48M | +3459.32% |
| TIL | Instil Bio Inc | $55.21M | +3441.67% |
| KZR | Kezar Life Sciences Inc | $53.76M | +3348.90% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $52.83M | +3289.44% |
| MREO | Mereo Biopharma Group Plc | $52.71M | +3281.63% |
| NBY | Stablecoin Development Corp | $52.10M | +3242.33% |
| RNTX | Rein Therapeutics Inc | $51.79M | +3222.85% |
| GOSS | Gossamer Bio Inc | $51.14M | +3180.88% |
| MGX | Metagenomi Inc | $50.82M | +3160.56% |
| ACTU | Actuate Therapeutics Inc | $50.03M | +3109.76% |
| INKT | MiNK Therapeutics Inc | $48.84M | +3033.43% |
| ESLA | Estrella Immunopharma Inc | $48.44M | +3007.60% |
| XLO | Xilio Therapeutics Inc | $48.23M | +2993.94% |
| CING | Cingulate Inc | $47.16M | +2925.33% |
| ATYR | Atyr Pharma Inc | $46.89M | +2908.08% |
| LVTX | LAVA Therapeutics NV | $45.77M | +2836.43% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +2833.58% |
| PSTV | Plus Therapeutics Inc | $45.56M | +2823.13% |
| ATOS | Atossa Therapeutics Inc | $44.09M | +2728.58% |
| KALA | Kala Bio Inc | $43.31M | +2678.81% |
| RNXT | RenovoRx Inc | $41.96M | +2591.77% |
| NTRB | Nutriband Inc | $41.39M | +2555.43% |
| HYPD | Eyenovia Inc | $41.14M | +2539.48% |
| FGEN | FibroGen Inc | $39.31M | +2421.66% |
| NNVC | NanoViricides Inc | $37.88M | +2330.29% |
| VERU | Veru Inc | $37.40M | +2299.20% |
| LTRN | Lantern Pharma Inc | $37.25M | +2289.95% |
| INMB | INmune Bio Inc | $37.22M | +2287.79% |
| ATNM | Actinium Pharmaceuticals Inc | $36.71M | +2255.03% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +2216.29% |
| GRCE | Acasti Pharma Inc | $36.05M | +2213.06% |
| GBIO | Generation Bio Company | $35.97M | +2207.54% |
| ABVC | ABVC BioPharma Inc | $35.82M | +2197.83% |
| MURA | Mural Oncology plc | $35.34M | +2167.38% |
| LITS | Lite Strategy Inc | $35.16M | +2155.42% |
| ALGS | Aligos Therapeutics Inc | $34.65M | +2123.20% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $34.30M | +2100.47% |
| DARE | Dare Bioscience Inc | $33.92M | +2076.36% |
| EVAX | Evaxion Biotech A/S | $33.82M | +2069.68% |
| BOLD | Boundless Bio Inc | $32.94M | +2013.14% |
| SNTI | Senti Biosciences Inc | $31.46M | +1918.06% |
| TVRD | Cara Therapeutics Inc | $30.96M | +1886.12% |
| LSTA | Lisata Therapeutics Inc | $30.05M | +1828.10% |
| TVGN | Tevogen Bio Holdings Inc | $29.97M | +1822.90% |
| APLM | Apollomics Inc - Class A | $29.93M | +1820.19% |
| NRSN | NeuroSense Therapeutics Ltd | $29.15M | +1770.00% |
| SKYE | Skye Bioscience Inc | $29.10M | +1767.07% |
| NEUP | Neuphoria Therapeutics Inc | $29.04M | +1762.89% |
| GRDX | Entero Therapeutics Inc | $28.95M | +1757.48% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.59M | +1733.93% |
| CRVO | CervoMed Inc | $28.15M | +1705.73% |
| IGC | IGC Pharma Inc | $28.00M | +1696.25% |
| DYAI | Dyadic International Inc DE | $27.40M | +1657.72% |
| ALLR | Allarity Therapeutics Inc | $27.37M | +1655.71% |
| SER | AgeX Therapeutics Inc | $26.82M | +1620.51% |
| PLRZ | Polyrizon Ltd | $26.52M | +1601.40% |
| CELU | Celularity Inc - Class A | $26.39M | +1593.00% |
| VTGN | VistaGen Therapeutics Inc | $26.36M | +1591.02% |
| BCTX | BriaCell Therapeutics Corp - New | $26.32M | +1588.50% |
| PTN | Palatin Technologies Inc | $26.08M | +1572.88% |
| TPST | Tempest Therapeutics Inc | $25.68M | +1547.22% |
| JSPR | Jasper Therapeutics Inc | $25.26M | +1520.82% |
| PLUR | Pluri Inc | $24.62M | +1479.27% |
| MRKR | Marker Therapeutics Inc | $24.21M | +1453.50% |
| HOWL | Werewolf Therapeutics Inc | $23.81M | +1427.68% |
| VYNE | VYNE Therapeutics Inc | $22.68M | +1354.81% |
| SNSE | Sensei Biotherapeutics Inc | $22.32M | +1331.71% |
| HOTH | Hoth Therapeutics Inc | $22.13M | +1319.60% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +1308.57% |
| NXTC | Nextcure Inc | $21.90M | +1304.85% |
| OPT | Opthea Ltd | $21.53M | +1281.21% |
| CRIS | Curis Inc | $21.11M | +1254.22% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +1207.23% |
| LGVN | Longeveron Inc - Class A | $19.70M | +1164.01% |
| GNTA | Genenta Science SpA | $19.23M | +1133.44% |
| AEON | AEON Biopharma Inc - Class A | $19.22M | +1133.23% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $18.90M | +1112.46% |
| XCUR | Exicure Inc | $17.78M | +1040.87% |
| INAB | IN8bio Inc | $17.72M | +1037.12% |
| PASG | Passage Bio Inc | $17.71M | +1035.99% |
| KTTA | Pasithea Therapeutics Corp | $17.28M | +1008.65% |
| MTVA | MetaVia Inc | $17.25M | +1006.60% |
| LPCN | Lipocine Inc | $17.04M | +993.40% |
| NCEL | NLS Pharmaceutics Ltd | $16.55M | +961.85% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $16.12M | +933.98% |
| HIND | ReShape Lifesciences Inc | $15.72M | +908.61% |
| COCP | Cocrystal Pharma Inc | $15.44M | +890.64% |
| CTXR | Citius Pharmaceuticals Inc | $15.44M | +890.53% |
| LEXX | Lexaria Bioscience Corp | $15.24M | +877.62% |
| CLRB | Cellectar Biosciences Inc | $14.97M | +860.24% |
| QNCX | Quince Therapeutics Inc | $14.89M | +855.52% |
| APLT | Applied Therapeutics Inc | $14.86M | +853.53% |
| HOOK | Hookipa Pharma Inc | $14.68M | +841.62% |
| BLRX | Bioline Rx Ltd | $14.66M | +840.77% |
| MBRX | Moleculin Biotech Inc | $14.57M | +834.62% |
| IOBT | IO Biotech Inc | $14.50M | +830.13% |
| ICU | SeaStar Medical Holding Corp | $14.34M | +819.81% |
| GDTC | CytoMed Therapeutics Ltd | $14.15M | +807.56% |
| GTBP | GT Biopharma Inc | $13.91M | +792.22% |
| CMMB | Chemomab Therapeutics Ltd | $13.67M | +776.69% |
| TOVX | Theriva Biologics Inc | $13.51M | +766.48% |
| CYCN | Cyclerion Therapeutics Inc | $13.36M | +757.10% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +735.33% |
| ERNA | Ernexa Therapeutics Inc | $12.99M | +733.32% |
| PHIO | Phio Pharmaceuticals Corp | $12.78M | +719.83% |
| CVKD | Cadrenal Therapeutics Inc | $12.33M | +691.25% |
| CALC | CalciMedica Inc | $11.72M | +652.20% |
| LNAI | Lunai Bioworks Inc | $11.72M | +651.61% |
| TRAW | Traws Pharma Inc | $11.70M | +650.44% |
| INTS | Intensity Therapeutics Inc | $11.33M | +626.92% |
| BIVI | BioVie Inc - Class A | $11.16M | +616.09% |
| KPRX | Kiora Pharmaceuticals Inc | $11.14M | +614.80% |
| BRTX | BioRestorative Therapies Inc | $11.03M | +607.59% |
| APRE | Aprea Therapeutics Inc | $10.96M | +603.10% |
| KAPA | Kairos Pharma Ltd | $10.68M | +585.44% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | +568.91% |
| CVM | Cel-Sci Corp | $10.15M | +550.89% |
| BOLT | Bolt Biotherapeutics Inc | $10.13M | +549.67% |
| MLEC | Moolec Science SA | $10.06M | +545.22% |
| BCDA | BioCardia Inc | $9.85M | +531.90% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.81M | +529.10% |
| CURX | Curanex Pharmaceuticals Inc | $9.73M | +524.17% |
| SNGX | Soligenix Inc | $9.11M | +484.17% |
| IMNN | Imunon Inc | $9.02M | +478.83% |
| EPIX | Essa Pharma Inc | $8.93M | +472.96% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | +472.10% |
| CANF | Can-Fite Biopharma Ltd | $8.80M | +464.43% |
| JUNS | Jupiter Neurosciences Inc | $8.70M | +458.39% |
| CELZ | Creative Medical Technology Holdings Inc | $8.54M | +447.84% |
| IMRN | Immuron Ltd | $8.36M | +436.19% |
| PMCB | PharmaCyte Biotech Inc | $8.16M | +423.44% |
| LIMN | Liminatus Pharma Inc | $8.08M | +418.24% |
| ITRM | Iterum Therapeutics Plc | $8.06M | +417.16% |
| NCNA | NuCana plc | $7.95M | +409.92% |
| ADXN | Addex Therapeutics Ltd | $7.90M | +406.74% |
| SYBX | Synlogic Inc | $7.72M | +395.36% |
| BCLI | Brainstorm Cell Therapeutics Inc | $7.66M | +391.73% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | +370.63% |
| XBIO | Xenetic Biosciences Inc | $7.06M | +353.24% |
| GNPX | Genprex Inc | $7.02M | +350.46% |
| ASBP | Aspire Biopharma Holdings Inc | $6.98M | +347.89% |
| EVGN | Evogene Ltd | $6.91M | +343.58% |
| SILO | SILO Pharma Inc | $6.78M | +335.17% |
| ACXP | Acurx Pharmaceuticals Inc | $6.74M | +332.68% |
| TCRT | Alaunos Therapeutics Inc | $6.68M | +328.76% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | +310.59% |
| GOVX | Geovax Labs Inc | $6.29M | +303.24% |
| APM | Aptorum Group Ltd - Class A | $6.26M | +301.33% |
| BCAB | BioAtla Inc | $6.19M | +297.14% |
| PPBT | Purple Biotech Ltd | $6.05M | +288.11% |
| APVO | Aptevo Therapeutics Inc | $5.83M | +273.77% |
| BGMS | Bio Green Med Solution Inc | $5.30M | +239.93% |
| CLGN | CollPlant Biotechnologies Ltd New | $5.25M | +236.84% |
| DRMA | Dermata Therapeutics Inc | $5.23M | +235.45% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.18M | +232.26% |
| HCWB | HCW Biologics Inc | $5.10M | +227.02% |
| PULM | Pulmatrix Inc | $4.97M | +218.66% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | +214.98% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $4.91M | +214.68% |
| MTNB | Matinas Biopharma Holdings Inc | $4.68M | +200.23% |
| RNAZ | TransCode Therapeutics Inc | $4.67M | +199.43% |
| ALZN | Alzamend Neuro Inc | $4.38M | +180.71% |
| MBIO | Mustang Bio Inc | $4.29M | +175.24% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | +173.64% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | +173.55% |
| REVB | Revelation Biosciences Inc | $4.26M | +173.31% |
| FBLG | FibroBiologics Inc | $4.23M | +171.10% |
| ENVB | Enveric Biosciences Inc | $4.15M | +166.41% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | +165.50% |
| GLMD | Galmed Pharmaceuticals Ltd | $4.08M | +161.78% |
| PHGE | BiomX Inc | $3.91M | +150.58% |
| PBM | Psyence Biomedical Ltd | $3.76M | +141.42% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.72M | +138.52% |
| ADIL | Adial Pharmaceuticals Inc | $3.61M | +131.40% |
| VIVS | VivoSim Labs Inc | $3.36M | +115.83% |
| XRTX | XORTX Therapeutics Inc | $3.34M | +114.40% |
| AZTR | Azitra Inc | $3.32M | +113.06% |
| GRI | GRI Bio Inc | $3.30M | +111.50% |
| SPRC | SciSparc Ltd | $3.05M | +95.39% |
| AFMD | Affimed N.V. | $2.98M | +90.87% |
| CMND | Clearmind Medicine Inc | $2.88M | +84.89% |
| ENSC | Ensysce Biosciences Inc | $2.88M | +84.52% |
| ARTL | Artelo Biosciences Inc | $2.75M | +76.18% |
| OGEN | Oragenics Inc | $2.58M | +65.35% |
| PPCB | Propanc Biopharma Inc | $2.50M | +60.49% |
| NTBL | Notable Labs Inc Ord | $2.39M | +53.62% |
| BBLG | Bone Biologics Corp | $2.23M | +42.82% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | +37.67% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | +33.96% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | +27.94% |
| AIM | AIM ImmunoTech Inc. | $1.74M | +11.90% |
| ONCO | Onconetix Inc | $1.61M | +3.40% |
| ZVSA | ZyVersa Therapeutics Inc | $1.55M | -0.28% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.55M | -0.34% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -2.52% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -8.47% |
| LYRA | Lyra Therapeutics Inc | $1.38M | -11.18% |
| JAGX | Jaguar Health Inc | $1.34M | -13.81% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -16.49% |
| PTIX | Protagenic Therapeutics Inc | $1.01M | -35.35% |
| BDRX | Biodexa Pharmaceuticals Plc | $919907.57 | -40.98% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -64.65% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -71.33% |
| ELAB | PMGC Holdings Inc | $221376.00 | -85.80% |
| ADTX | Aditxt Inc | $132564.52 | -91.50% |
| CDT | CDT Equity Inc | $110551.31 | -92.91% |